No Data
Chao Yan Co., Ltd. (301602.SZ): Plans to increase investment in Shenzhen Shanchao with its own funds of 0.5 million yuan.
On April 28, Gelonghui reported that Chao Research Co., Ltd. (301602.SZ) announced that the company held the eighth meeting of the second Board of Directors on April 27, 2025, where the proposal for increasing capital to its subsidiary was approved. According to the company's development Global Strategy and the operational management needs of its wholly-owned subsidiary, Shenzhen Shanchao Technology Co., Ltd. (hereinafter referred to as "Shenzhen Shanchao"), the company plans to increase capital by 0.5 million yuan using its own funds. After this capital increase is completed, the registered capital of Shenzhen Shanchao will be increased from 0.5 million yuan to 1 million yuan, still remaining a wholly-owned subsidiary of the company.
Super Research Co., Ltd. (301602.SZ): Successfully developed the Asia Vets full-volume ultrasound IBUS series products suitable for early screening of breast tumors.
On March 10, Gelonghui reported that Chao Yan Co., Ltd. (301602.SZ) stated on the investor interaction platform that the company will introduce intelligent technology into imaging products to achieve intelligent clinical diagnosis such as fetal measurements, breast tumor identification, and myocardial function assessment. It has successfully developed the intelligent breast all-volume ultrasound (IBUS) product series suitable for early screening of breast tumors, and since 2024 it will implement a screening program based on AI breast intelligent examination technology called 'full-volume scan + volume AI diagnosis', forming a specialized series and screening series of breast products. At the same time, the company is developed along with Siasun Robot&Automation System Applications.
Chao Yan Co., Ltd. (301602.SZ) plans to set up a wholly-owned subsidiary in Hong Kong.
Chao Yan Co., Ltd. (301602.SZ) announces that the second session of the Board of Directors will be held on February 13, 2025...
Chao Research Co., Ltd. (301602.SZ): No DRG/DIP products available at the Hospital end.
On February 11, Gelonghui reported that Chaoyan Co., Ltd. (301602.SZ) stated on the investor interaction platform that the company's main Business is the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, and there are currently no DRG/DIP Hospital end products.
ChaoYan Co., Ltd. (301602.SZ): The company has not yet connected to DeepSeek.
On February 6th, Gelonghui reported that Chao Yan Co., Ltd. (301602.SZ) mentioned on the investor interaction platform that the company has not yet connected to DeepSeek.
ChaoYan Co., Ltd. (301602.SZ): There is currently no cooperation, investment, or joint research project with DeepSeek in the field of Medical robots technology.
On February 6, Glonghui reported that Super Research Co., Ltd. (301602.SZ) stated on the investor interaction platform that there are currently no cooperative investments or joint research and development projects with DeepSeek in Medical robotics technology.
